Bristol-Myers Squibb Company (BMY) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Bristol-Myers Squibb Company (BMY) short-term stock forecast for year 2025, month by month, and long-term BMY price prediction for years 2025 to 2050. Check BMY historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest BMY news and headlines.
1 Month Prediction
$97.27 [64.06%]
3 Month Prediction
$93.90 [58.39%]
6 Month Prediction
$100.32 [69.22%]
1 Year Prediction
$103.76 [75.03%]
3 Year Prediction
$103.89 [75.24%]
5 Year Prediction
$101.00 [70.37%]
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMS) is an American multinational biopharmaceutical company that develops and manufactures prescription pharmaceuticals and biologics across oncology, immunology, cardiovascular diseases, and infectious diseases such as HIV/AIDS. BMS was established in 1989 through merger of two companies, Bristol-Myers and Squibb Corporation.
The company has major facilities in Lawrence and Summit in New Jersey, Redwood City in California, and Seville in Spain. Its other sites are situated in Massachusetts (Devens and Cambridge), Belgium (Braine-l'Alleud), Japan (Tokyo), India (Hyderabad and Bangalore), and the United Kingdom (Wirral).
Bristol-Myers Squibb Company (BMY) Historical Performance
IPO Date
Bristol-Myers Squibb Company (NYSE:BMY) went public on 05 July, 1929.
Change
Since inception, BMY has increased by 3,683.47%. In the last 5 years, BMY has risen from $50.77 to $59.28, a minor 16.77% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $72.98 and a low of $39.59.
52 Week Range
$39.35
$63.33
The current price $59.30 is near the 52-week high, which means that the stock is overbought.
BMY Stock Price History
Based on BMY stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the BMY stock has risen from $46.54 - $53.33 to $58.31 - $59.62, which is up 41.23%. Currently, the stock follows upward trend.
Here, we have calculated stock range of BMY, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $46.54 - $53.33 | $50.65 | 21.1 | 1 Year Change |
| 2021 | $47.29 - $58.92 | $54.36 | 29.97 | 2 Year Change |
| 2022 | $57.21 - $72.98 | $65.59 | 56.82 | 3 Year Change |
| 2023 | $46.49 - $66.04 | $57.03 | 36.35 | 4 Year Change |
| 2024 | $39.59 - $58.57 | $48.48 | 15.91 | 5 Year Change |
| 2025 | $58.31 - $59.62 | $59.07 | 41.23 | 6 Year Change |
BMY Price Performance
6-Month Performance
BMY stock jumped by 8.68% in the last six months.
1-Year Performance
The stock has trended upwards by 41.67% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 12.09%.
5-Year Performance
In the last 5 years, the stock has gone up by 16.77%.
According to Bristol-Myers Squibb Company's historical data, below graph gives us the exact picture of how the BMY stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
0.39% ↓
2021
3.70% ↑
2022
18.98% ↑
2023
26.14% ↓
2024
15.81% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Bristol-Myers Squibb Company (BMY) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $12.34 B (Q4)
Revenue for Q4 ending 31st December, 2024 increased 3.78% compared to Q3 ending 30th September, 2024.
Annual Revenue: $48.30 B (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
Market Capitalization
Bristol-Myers Squibb Company has a market capitalization of $120.65B, which places BMY in the large-cap category.
Fundamental Analysis
EPS: $nan (Q4), $nan (1Y)
EPS decreased nan% since last quarter, and decreased nan% since last year.
Net Income: $72.00 M (Q4), $-8.95 B (1Y)
Net Income decreased 94.05% since last quarter, and decreased 211.50% since last year.
Free Cash Flow: $4.06 B (Q4), $13.94 B (1Y)
Free Cash Flow decreased 22.90% since last quarter, and increased 10.20% since last year.
Net Profit Margin: 0.58% (Q4), -18.53% (1Y)
Net Profit Margin decreased 94.27% since last quarter, and decreased 211.50% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for BMY stock. These indicators help you understand Bristol-Myers Squibb Company's financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for BMY stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $60.16 |
| SMA50 | $58.58 |
| SMA200 | $52.14 |
| RSI | 30.63 |
| Beta | 0.44 |
SMA20 > Current Price
This signals BMY stock is in short-term bearish momentum.
SMA50 < Current Price
This signals BMY stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals BMY stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for BMY stock is Neutral. Out of all indicators, 4 indicates bullish signals, 1 signals bearish trends and 4 gives neutral trends. The BMY stock forecast was last updated on 28 March, 2025.
Bristol-Myers Squibb Company (BMY) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $97.93 by the end of 2025, and can reach around $110.91 to $96.17 in 2026. And, the long-term forecast suggests that the stock may further jump to $98.56 - $81.75 in 2028, and $91.21 - $86.85 by 2031. So, the BMY stock shows a strong upward trend in the next several years.
Short-term BMY Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $97.27 | 64.07% |
| 2025-05 | $94.40 | 59.23% |
| 2025-06 | $93.90 | 58.39% |
| 2025-07 | $98.53 | 66.2% |
| 2025-08 | $100.03 | 68.73% |
| 2025-09 | $100.32 | 69.22% |
| 2025-10 | $95.48 | 61.05% |
| 2025-11 | $94.96 | 60.18% |
| 2025-12 | $97.93 | 65.19% |
In 2025, the BMY stock price is expected to fluctuate between $93.9 and $100.32. According to the monthly forecast, the stock could rise to $97.93 by December 2024. If compared to the BMY's current price, the stock could gain 65.19% by the end of this year.
Long-term BMY Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $110.91 | $101.58 | $96.17 | 62.22% |
| 2027 | $97.98 | $99.94 | $74.66 | 25.93% |
| 2028 | $98.56 | $96.92 | $81.75 | 37.89% |
| 2029 | $90.68 | $104.89 | $97.53 | 64.51% |
| 2030 | $87.26 | $97.06 | $92.52 | 56.06% |
| 2031 | $91.21 | $95.82 | $86.85 | 46.5% |
| 2032 | $89.00 | $84.57 | $82.87 | 39.78% |
| 2033 | $95.97 | $104.09 | $88.64 | 49.52% |
| 2034 | $87.05 | $84.95 | $84.25 | 42.11% |
| 2035 | $95.32 | $91.57 | $77.86 | 31.33% |
| 2036 | $92.99 | $97.60 | $93.82 | 58.25% |
| 2037 | $81.22 | $97.14 | $84.94 | 43.27% |
| 2038 | $92.90 | $87.87 | $78.34 | 32.14% |
| 2039 | $75.80 | $80.09 | $82.58 | 39.29% |
| 2040 | $79.65 | $79.08 | $73.74 | 24.38% |
| 2041 | $87.50 | $84.39 | $76.16 | 28.46% |
| 2042 | $87.47 | $80.32 | $71.55 | 20.69% |
| 2043 | $80.90 | $93.54 | $72.58 | 22.43% |
| 2044 | $84.01 | $90.80 | $71.81 | 21.13% |
| 2045 | $89.61 | $79.99 | $71.23 | 20.15% |
| 2046 | $79.78 | $73.92 | $78.01 | 31.58% |
| 2047 | $75.60 | $78.62 | $71.12 | 19.96% |
| 2048 | $81.08 | $77.14 | $70.43 | 18.8% |
| 2049 | $74.48 | $81.26 | $66.59 | 12.32% |
| 2050 | $73.09 | $87.48 | $64.86 | 9.4% |
| 2051 | $68.95 | $76.09 | $71.45 | 20.52% |
Bristol-Myers Squibb Company (BMY) Stock Price Prediction & Forecast 2025
At the start of 2025, the BMY stock was at $58.31. Today, it is trading at $59.28, which is 1.68% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $97.93 by December 2025 with a 65.19% change.
Bristol-Myers Squibb Company (BMY) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the BMY stock. During this period, the BMY's price is forecasted to shift from $110.91 to $92.52, which is -16.58% loss.
In 2026, the stock would possibly open at $110.91, descends to $101.58 by mid-year, and wraps up at $96.17, reflecting a 62.21% increase from today's price. Further moving to 2030, the stock can kick off the year at $87.26, drop to $97.06 by mid-year, and finish at $92.52, which is 56.05% change from current price.
Bristol-Myers Squibb Company (BMY) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $91.21 to $73.74, which is down 46.49%
In 2031, we can expect BMY to fluctuate between $86.85 and $91.21, a shift indicating a 46.49% gain by year-end compared to current price. And Until 2040, BMY can likely vary from $73.74 to $79.65. By the end of 2040, the stock could record a 24.38% rise from today's stock price.
Bristol-Myers Squibb Company (BMY) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the BMY stock can see an a downturn from $87.50 to $64.86 in this period. In 2041, the stock can experience a low of $84.39 by mid-year, closing the year at $76.16. This results in a 42.35% increase from today.
Moving towards the end of 2050, BMY is projected to open the year at $73.09. The stock may peak to $87.48 during mid-year and finish the year at $64.86. Compared to the stock's current price, this translates to an overall gain of 9.40% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
BMY Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | - | $87.87 | -3.93% ▼ | $146.41 ▲ |
| ABBV | AbbVie Inc. | - | $210.75 | 0.82% ▲ | $81.29 ▲ |
| NVO | Novo Nordisk A/S | - | $73.60 | -18.81% ▼ | $247.89 ▲ |
| LLY | Eli Lilly and Company | - | $844.27 | 4.09% ▲ | $112.92 ▲ |
| JNJ | Johnson & Johnson | - | $163.63 | -0.05% ▼ | $80.87 ▲ |
Last updated Mar 28 at 5:40 PM
BMY : Buy, Sell Or Hold?
Analyst Ratings
Based on 23 analysts, 2 rated as a strong buy, 2 recommended a buy, 18 suggested a hold, 1 advised a sell, and 0 indicated a strong sell.Three months ago, out of 22 analysts, 4 analysts gave a strong buy rating, 3 a buy rating, 15 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for BMY stock is Hold.
Expert Analysis
According to BMY short-term and long-term forecast, Bristol-Myers Squibb Company shares are projected to go up by 9.4%, and reach a value of $64.86 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 71.42857142857143, which signals Greed. Also, BMY has recorded 14/30 green days, which reflects a 60.86956521739131% positivity rate with a price volatility of 0.02%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that BMY stock is undervalued. So, Based on BMY prediction and analysis, it may be the best time to hold BMY stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "BMY” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.